OCULAR THERAPEUTIX, INC (OCUL) › Operating IncomeOCULAR THERAPEUTIX, INC (OCUL) — Operating IncomeAnnual figures by period end, from SEC filings.2012-12-31: -$13.67M2013-12-31: -$12.90M2014-12-31: -$27.09M2015-12-31: -$38.20M2016-12-31: -$43.33M2017-12-31: -$61.92M2018-12-31: -$59.12M2019-12-31: -$85.80M2020-12-31: -$62.85M2021-12-31: -$78.04M2022-12-31: -$78.65M2023-12-31: -$82.38M2024-12-31: -$171.78M2025-12-31: -$270.02M-$270.02M2012-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31-$270.02M—2026-02-05From 2025-01-012024-12-31-$171.78M—2026-02-05From 2024-01-012023-12-31-$82.38M—2026-02-05From 2023-01-012022-12-31-$78.65M—2025-03-03From 2022-01-012021-12-31-$78.04M—2024-03-11From 2021-01-012020-12-31-$62.85M—2023-03-06From 2020-01-012019-12-31-$85.80M—2022-02-28From 2019-01-012018-12-31-$59.12M—2020-03-12From 2018-01-012017-12-31-$61.92M—2020-03-12From 2017-01-012016-12-31-$43.33M—2019-03-07From 2016-01-012015-12-31-$38.20M—2018-03-08From 2015-01-012014-12-31-$27.09M—2017-03-10From 2014-01-012013-12-31-$12.90M—2016-03-10From 2013-01-012012-12-31-$13.67M—2015-03-20From 2012-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)